Citadel Advisors’s Atossa Therapeutics ATOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,720
Closed -$50.6K 12958
2025
Q4
$50.6K Buy
5,720
+4,040
+240% +$51.1K ﹤0.01% 12029
2025
Q3
$21.8K Buy
1,680
+833
+98% +$10.3K ﹤0.01% 12477
2025
Q2
$10.5K Sell
847
-1,406
-62% -$16.8K ﹤0.01% 12196
2025
Q1
$22.7K Buy
2,253
+860
+62% +$10.4K ﹤0.01% 13049
2024
Q4
$19.7K Sell
1,393
-3,114
-69% -$60.8K ﹤0.01% 13190
2024
Q3
$103K Buy
4,507
+1,667
+59% +$33.7K ﹤0.01% 11078
2024
Q2
$50.7K Sell
2,840
-773
-21% -$17.1K ﹤0.01% 11742
2024
Q1
$97.6K Buy
3,613
+2,253
+166% +$36.2K ﹤0.01% 11390
2023
Q4
$18K Sell
1,360
-360
-21% -$3.88K ﹤0.01% 12713
2023
Q3
$19K Sell
1,720
-2,053
-54% -$29.8K ﹤0.01% 12669
2023
Q2
$71.3K Sell
3,773
-447
-11% -$5.42K ﹤0.01% 11372
2023
Q1
$45.9K Sell
4,220
-2,253
-35% -$25.1K ﹤0.01% 12269
2022
Q4
$51.3K Sell
6,473
-1,507
-19% -$17.3K ﹤0.01% 12103
2022
Q3
$100K Buy
7,980
+60
+0.8% +$871 ﹤0.01% 11094
2022
Q2
$129K Sell
7,920
-2,373
-23% -$37.4K ﹤0.01% 11142
2022
Q1
$193K Sell
10,293
-5,220
-34% -$106K ﹤0.01% 11582
2021
Q4
$372K Sell
15,513
-22,647
-59% -$829K ﹤0.01% 10418
2021
Q3
$1.87M Sell
38,160
-23,213
-38% -$1.35M ﹤0.01% 6539
2021
Q2
$5.82M Buy
61,373
+32,740
+114% +$1.73M 0.01% 4111
2021
Q1
$906K Buy
28,633
+25,140
+720% +$919K ﹤0.01% 8364
2020
Q4
$50K Buy
3,493
+1,833
+110% +$42.4K ﹤0.01% 10565
2020
Q3
$60K Buy
1,660
+500
+43% +$24K ﹤0.01% 9532
2020
Q2
$66K Buy
+1,160
New +$41.1K ﹤0.01% 9184
2020
Q1
Sell
-733
Closed -$17K 9565
2019
Q4
$17K Sell
733
-87
-11% -$2.04K ﹤0.01% 8958
2019
Q3
$24K Sell
820
-313
-28% -$9.91K ﹤0.01% 8894
2019
Q2
$43K Buy
+1,133
New +$45.4K ﹤0.01% 8768

Other funds holding ATOS